London Stock Exchange (LSE) · Financial Services
IntegraFin Holdings plc IHP
MonitorScore band: 60–70
The thesis, in one sentence
A high-quality investment platform — almost entirely recurring revenue, no debt and high returns on equity — but at the top of its yearly range with no margin of safety, and most of the growth in assets came from markets rather than net inflows.
Written for this site in plain English, without figures. The arithmetic is in the full report.
The thesis is from the deep report of 2026-08-24; the verdict badge reflects the latest scoring of 2026-09-06.
Key risks
- Most growth in assets came from markets, not from net inflows
- The shares sit at their yearly high with no margin of safety
- The consensus profit re-rating rests on an efficiency program
What would change the verdict
- Return on equity falls, breaking the quality case
- Operating margin falls for two consecutive quarters as the cost program slips
- Asset growth turns negative for two consecutive quarters
- Net-flow market share falls, showing the switching moat is failing
Read it yourself
Step five of the method is the reader's: open the latest annual or quarterly report and read it before acting on anything here. A score is a summary, and a summary is not understanding.
Filings at London Stock Exchange news →
This exchange has no stable per-company address, so the link opens the disclosure portal — search there for the ticker.
The deep report was written against the filings available on 2026-08-24; anything published since is not in it.
Price, one year
DCF valuation range
range of the DCF modelsbase casetoday's price
Valuation range, shape only. Figures in the full version.
Monte Carlo outcome shape
scenarios below today's pricescenarios above today's pricetoday's price
Distribution of simulated outcomes around today's price. Bar heights only; the scale and the percentiles are in the full version.
Where the money goes
Last four reported quarters, 2022-09 → 2025-09, in GBP. Filings data as gathered on 2026-08-24. Figures rounded to three significant digits.
Chapter one: Executive summary
IHP — IntegraFin Holdings plc (Transact) · deep-value analysis
Analysis date: 08/24/2026 · Exchange: LSE (Main Market, FTSE 250) · ISIN: GB00BD45SH49 Yahoo symbol: IHP.L · Reference price: … GBp (08/24/2026, yfinance) · Market cap: ~… Shares: 331.3 mil issued / 330.4 mil basic weighted average · Fiscal year: ends September 30 Currencies: reporting GBP (millions), price GBp (pence) — … = 100 GBp, any yield relative to market cap requires a ×100 conversion
Identification note (symbol collision). The bare symbol "IHP" doesn't resolve on Yahoo to the tracker's company: today's first run of
deep_data_pack.pyproduced a completely empty file, named "141752." The historical NYSE ticker "IHP" was IHOP Corp (today Dine Brands, DIN). The company in the tracker (Sumar r309, Exchange=LSE, ISIN GB00BD45SH49) is IntegraFin Holdings plc, the operator of the investment platform for financial advisers Transact, listed underIHP.L. I added the collision to_BVB_ALIASESindeep_data_pack.pyand regenerated the data pack. It's NOT an SEC issuer — no CIK, no 10-K/20-F filings; the primary filings are RNS releases and annual reports from integrafin.co.uk, which I downloaded and read directly (Annual Report 2025, 144 pages; Annual Report 2024; Annual Report 2023; Half-year report at 03/31/2026; FY26 Q3 Trading Update from 07/14/2026). For this reason there's noSEC-Filings\IHP\folder and step 2 of the procedure doesn't apply.
Executive summary
The thesis. IntegraFin operates Transact, the UK's largest investment platform for financial advisers, built entirely on proprietary technology. The economic model has a rare simplicity: a monthly ad valorem fee applied to assets under administration (funds under direction, FUD), of which 99% of platform revenue is recurring (AR2025, p45). At 06/30/2026 FUD was …, … y/y, and the quarter's average daily FUD — the real revenue base — was …, … (Q3 Trading Update, 07/14/2026). The company has zero financial debt, equity of …, ROE ~29%, and capex that in normal years is under …. Since December 2025 an efficiency program has been running that caps administrative expense growth at ~3%/year in FY26 and FY27, versus … in FY25 — and in the half ended 03/31/2026, growth was already capped at 4%, with PBT margin above 51%.
What's wrong with the headline numbers. The consolidated balance sheet shows … of assets and … of liabilities, and the cash flow statement shows CFO of … on a net profit of …. Both are accounting artifacts: the life-insurance subsidiaries (ILUK, ILInt) write exclusively unit-linked policies, and IFRS requires the policies' assets and liabilities to appear gross on the balance sheet, in the income statement AND in the cash flow statement, with a net effect of exactly zero (AR2025, p46). Of the … of CFO, 272.2 mil is the movement of client money — visible without doubt in the fact that total group cash grew by exactly …, and cash held for policies grew by exactly … (1,895.0 − 1,622.8), while corporate cash fell by … (243.9 vs 244.1). Consequently CFO − capex = … isn't the flow to the shareholder, it's 5.8× larger than it. The real flow, reconstructed from the shareholder's liquid-asset roll-forward, is … in FY25 (see the valuation chapter). This is the largest FCF-bridge divergence encountered across the deep-report series — four times larger than the AFYA reference case (73%).
Estimated value. Five triangulated models give a wide range, centered very close to the current price: base DCF FCFE … (… versus …), bear DCF … (…), bull DCF … (…), Greenwald EPV … (…), 5-year historical multiples … (…). Model median: …. The Monte Carlo simulation across 20,000 scenarios (same central assumptions, dispersion on owner earnings ±25%, g1 σ=4.5pp, r σ=100bp, gt σ=50bp) gives a median intrinsic value of … and a probability of undervaluation of …% — practically a coin flip. The broker consensus target (428–…, 9–11 analysts) is 8… above the price, so the market doesn't see a big discount either.
The verdict. A high-quality business — a real moat through switching costs for advisory firms, 99% recurring revenue, zero debt, ROE 29%, growing share of net market flows (≈25% in H1 FY26), and a pricing policy that has cut fees 18 times in 17 years, which widens the moat rather than filling it in. But the price leaves no margin of safety. At … the stock is at the top of its 52-week range (306–… on monthly closes), at 20.8x TTM profit and 5.6x book value, with FUD at an all-time high reached through a +… market move in a single quarter. Nearly half of the next two years' profit growth is already in consensus and in the price. Verdict: WATCH, don't buy at …. Threshold of interest: below ~… (FY26E P/E ~16x, base-case DCF MOS ≈ …), where the Monte Carlo range would move the probability of undervaluation above 60%.
Figures were removed from this excerpt. The full report opens free for five tickers a week — see what's open now.
Full report contents
- Executive summary
- 🔒 The business and the moat (Available in the full report)
- 🔒 Management and capital allocation (Available in the full report)
- 🔒 What changed over the last 4 quarters (Available in the full report)
- 🔒 Balance sheet analysis — Quality of Earnings (Thornton O'Glove method) (Available in the full report)
- 🔒 CEO profile — Outsider traits (William Thorndike method) (Available in the full report)
- 🔒 Accounting red flags (Available in the full report)
- 🔒 Triangulated valuation (Available in the full report)
- 🔒 Pre-mortem (Available in the full report)
- 🔒 Verdict compared with the tracker's GBL score (Available in the full report)
Evaluation history
| Date | Verdict |
|---|---|
| 2026-08-23 | Interesting |
| 2026-08-24 | Monitor |
| 2026-09-06 | Monitor |
Want the rest of this report?
Subscribe to get one full deep report a week by email, the day before it opens on the site.